Nature Communications is an open access journal publishing high-quality research in all areas of the biological, physical, chemical and Earth sciences.
Our Early Career Researchers (ECR) Co-Review Initiative ensures that #ECR are recognised for their contribution to peer-review and that they can get involved in peer-review alongside more experienced researchers.
Learn more:
https://t.co/PrQwvmXHOn
https://t.co/oZulqehdv1
In this comment, Prof. Jier Huang, @AKing_MatSci et al. outline common pitfalls and offer recommendations for using transient absorption spectroscopy in MOF and COF photocatalysts, emphasizing clear data presentation to enable deeper mechanistic insights. https://t.co/qsh5feV6YT
🚨New collection🚨
Initially Anode-less and Anode-free Batteries
We welcome submissions studying current collectors, electrolytes, and interfacial chemistry that overcome the demanding conditions in initially anode-less and anode-free batteries🔋
https://t.co/NqGNggNpl9
Weihao Wang et al. demonstrate that a reverse-pulse charging method can reactivate dead sodium in initially anode-free sodium batteries, enhancing rate performance and cycle life.
https://t.co/MWvDBfj3lP
How can sodium batteries last longer at high voltage? Jiyu Zhang et al. develop a dual-domain solvent-locked electrolyte that stabilizes the positive electrode interphase and extends the cycle life of 4.5 V-class sodium batteries.
https://t.co/8I4MsJAJ2w
Announcing Nature Progress Oncology! An open-access journal in the new Nature Progress series, publishing significant advances in cancer research, from cell biology and immunology, therapeutics, clinical research, and epidemiology
https://t.co/dabFW0XBsX
Announcing Nature Progress Brain Health! A new open-access journal bringing together timely research across the full landscape of brain health, including preclinical and translational neuroscience, neurology, and neuropsychiatry
https://t.co/SpweYWOUlL
Comment by Prof @icouzin that explores how collective intelligence emerges from local interactions in animal groups, and how these principles inform the design of swarm robotic systems. @NatureComms@NaturePortfolio
https://t.co/iIgxpbuYM1
Save the date! We are hosting the webinar "Inflammatory cell death and anti-tumor immunity".
Join us and our speakers Dmitri Krysko, Judy Lieberman, @deadoc80, Pascal Meier
📅 Tuesday 14th Oct 2025
⏰ 16.00 PM (GMT+1)
Register here: https://t.co/sKabeNYkQv
🧬 Don’t miss the 2nd Meeting on Epigenetics & Epigenomics in Health & Disease! Our editor Dr P. Mallini will be there. 📅Sept 24–26, 2025 | 📍Brussels
🔗https://t.co/z0HJWPWFWm #Epigenetics2025#Epigenomics
I will be attending the 2nd European Fluid Dynamics Conference in Dublin from August 26 to August 29, 2025. Feel free to reach out if you will be attending as well. #Fluids#Softmatter#physics@NatureComms
New collection alert!
NeuroAI and Embodied Intelligence
We welcome submissions that explore neurobiologically-inspired models, architectures, and learning algorithms that have the potential to enhance embodied AI and robotic systems.
https://t.co/5vhXaMbXFB
Our editor Laura Sanchez Burgos will be from tomorrow at the @EACRnews congress on Persister Cells: from Bacteria to Cancer! Please go say hi if you want to learn more about our journal or our open collection on Drug-tolerant persister cells in cancer https://t.co/rBpXk9wKZi
We are looking for a new editor in Battery and electrochemistry. Hiring location: Milan, Madrid, New York, Philadelphia, Shanghai. Deadline 30 March: https://t.co/HBM9mGxuvg
@AlbertoArdid and colleagues present new work in which they use transfer machine learning methods that help forecasting volcanic eruptions, also at less monitored volcanoes.
https://t.co/0HiHxkmTrj
Our editor Laura Sanchez Burgos will be attending the @EACRnews congress on Persister Cells: from Bacteria to Cancer in Lyon next month! Please go say hi if you want to learn more about our journal or about our open collection on DTPs in cancer https://t.co/rBpXk9wKZi
Our cross-journal collection on Drug-tolerant persister cells in cancer is now open! We welcome submissions aiming to elucidate the molecular mechanisms, potential therapeutic targets and biomarkers of drug-tolerant persister cells for cancer. @CommsBio https://t.co/rBpXk9wKZi